Amgen Inc (AMGN) operating KPIs
AMGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 17/3039% above fair value
$466.01+5.28 (+1.15%)
Close on Oct 30, 2026Market cap $251.94BP/E 28.9Yield 2.07%
Amgen major Customer Concentration — McKesson Corporation Gross Product Sales ($M) ($M)
Form 10-K Note 1 Concentration of Credit Risk & Major Customers (XBRL)
Latest, FY2025
20,986
Period ended Dec 31, 2025
Change on a year earlier
+14.1%
18,387 in FY2024
History
11 years
Since FY2015
Sources
8
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Major Customer Concentration — McKesson Corporation Gross Product Sales ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 20,986 | +14.1% | Form 10-K (filed 2026-02-13) ↗ |
| FY2024 | Dec 31, 2024 | 18,387 | +10.6% | Form 10-K (filed 2026-02-13) ↗ |
| FY2023 | Dec 31, 2023 | 16,625 | +7.7% | Form 10-K (filed 2026-02-13) ↗ |
| FY2022 | Dec 31, 2022 | 15,443 | +4.5% | Form 10-K (filed 2025-02-14) ↗ |
| FY2021 | Dec 31, 2021 | 14,783 | +0.3% | Form 10-K (filed 2024-02-14) ↗ |
| FY2020 | Dec 31, 2020 | 14,743 | +19.9% | Form 10-K (filed 2023-02-09) ↗ |
| FY2019 | Dec 31, 2019 | 12,301 | +1.7% | Form 10-K (filed 2022-02-16) ↗ |
| FY2018 | Dec 31, 2018 | 12,091 | +12.6% | Form 10-K (filed 2021-02-09) ↗ |
| FY2017 | Dec 31, 2017 | 10,742 | +6.4% | Form 10-K (filed 2019-02-13) ↗ |
| FY2016 | Dec 31, 2016 | 10,100 | +0.6% | Form 10-K (filed 2019-02-13) ↗ |
| FY2015 | Dec 31, 2015 | 10,038 | – | Form 10-K (filed 2018-02-13) ↗ |
Breakdown
What makes up major customer concentration — mckesson corporation gross product sales ($m)
- McKesson Corporation — Share of Worldwide Gross Revenues (%)27.0% · FY2025
- McKesson Corporation — Share of U.S. Gross Product Sales (legacy disclosure) (%)39.0% · FY2018
- Cencora, Inc. (formerly AmerisourceBergen) — Gross Product Sales ($M)26,253 · FY2025
- Cardinal Health, Inc. — Gross Product Sales ($M)12,562 · FY2025
- Top 3 Wholesalers Combined — Share of Worldwide Gross Revenues (%)77.0% · FY2025
- Top 3 Wholesalers Combined — Share of U.S. Gross Product Sales (legacy disclosure) (%)98.0% · FY2018
- Top 3 Wholesalers Combined — Share of Total Net Trade Receivables (%)75.0% · FY2025
- Share of Net Trade Receivables Held Outside the United States (%)21.0% · FY2025
Cite this data
StockData. (2026). Amgen Major Customer Concentration — McKesson Corporation Gross Product Sales ($M) ($M), annual FY2015–FY2025 [Data set]. Compiled from Amgen SEC filings and investor materials. https://stockdatahq.com/stocks/amgn/kpis/conc_mckesson_sales
See every metric in the Amgen KPI table. Data updated Oct 28, 2026.